DOCSLIB.ORG
Explore
Sign Up
Log In
Upload
Search
Home
» Tags
» Dopaminergic
Dopaminergic
Biased Allosteric Regulation of the Prostaglandin F2α Receptor: From
Phencyclidine: an Update
Lysergic Acid Diethylamide (LSD) Promotes Social Behavior Through Mtorc1 in the Excitatory Neurotransmission
Roles for the Uptake 2 Transporter OCT3 in Regulation Of
Sex Differences in Serotonergic and Dopaminergic Mediation of LSD Discrimination in Rats
Dopamine Agonists 1
Phencyclidine Increases Forebrain Monoamine Metabolism in Rats and Monkeys: Modulation by the Isomers of HA966
Dopaminergic Function and Dopamine Transporter Binding Assessed with Positron Emission Tomography in Parkinson Disease
Molecular Regulation in Dopaminergic Neuron Development
Development and Differentiation of Midbrain Dopaminergic
Emulated Clinical Trials from Longitudinal Real-World
The Kappa Opioid Agonist, Salvinorin A, Attenuates Locomotor Effects of Morphine but Not Morphine-Induced Conditioned Place Preference
Involvement of Dopamine D2 and 5-HT IA Receptors in Roxindole-Induced Antinociception
Lysergic Acid Biethylamide Binds to a Novel Serotonergic Site on Rat Choroid Plexus Epithelial Cells’
Dopamine Agonists Diminish Value Sensitivity of the Orbitofrontal Cortex: a Trigger for Pathological Gambling in Parkinson’S Disease?
Fibromyalgia-Like Syndrome Associated with Parkinson's Disease (FLISPAD)
Importance of Dopamine in Parkinson's Disease
New Information of Dopaminergic Agents Based on Quantum Chemistry Calculations Guillermo Goode‑Romero1*, Ulrika Winnberg2, Laura Domínguez1, Ilich A
Top View
Salvinorin A, an Herbal Secondary Metabolite from Salvia Divinorum As an Anti-Neuropathic Pain Scaffold
Monoamine Oxidase and Cerebral Uptake of Dopaminergic Drugs (Dopamine/Noradrenaline/Adrenaline/Apomorphine/Nialamilde) GEORGE C
Lysergic Acid Diethylamide As a Multi-Target Therapeutic for Alzheimer’S Disease
Titel Constitutive Activity of the Human Histamine H4 Receptor: Molecular Modelling, Binding and Functional Studies on Wild-Type and Mutant H4R Orthologs
Rapid Development of Dopaminergic Supersensitivity in Reserpine- Treated Rats Demonstrated with 14C-2-Deoxyglucose Autoradiography
Dopamine-Serotonin
Phencyclidine-Induced Behavioral Sensitization
In Silico Studies Targeting G-Protein Coupled Receptors for Drug Research Against Parkinson’S Disease
The Neurotransmitter Dopamine and Dopaminergic Pathways
Selective Effects of Low-Dose D2 Dopamine Receptor Antagonism In
Dopamine D2 Receptors in Dopaminergic Neurons Modulate Performance in a Reversal Learning Task in Mice
A Complete Assessment of Dopamine Receptor- Ligand Interactions Through Computational Methods
Neuropsychiatric and Metabolic Aspects of Dopaminergic Therapy: Perspectives from an Endocrinologist and a Psychiatrist
Persistent Behavioral Sensitization to Chronic L-DOPA Requires A2A Adenosine Receptors
Effect of Lysergic Acid Diethylamide (LSD) on Reinforcement Learning in Humans
Dopamine Agonists: Their Role in the Treatment of Parkinson's Disease
4 -F-PCP) in Rodents
Molecular Mechanisms by Which Salvinorin a Binds to and Activates the Kappa-Opioid Receptor
The Glycine/NMDA Receptor Antagonist, R-(+)-HA-966
Induction of Apoptosis in Catecholaminergic PC12 Cells by L-DOPA Implications for the Treatment of Parkinson's Disease Gail Walkinshaw and Catherine M
Novel Insights in Dopamine Receptor Physiology
Dopamine Receptors and the Kidney: an Overview of Health- and Pharmacological-Targeted Implications
Hyperfunction of Dopaminergic and Serotonergic Neuronal Systems in Mice Lacking the NMDA Receptor ⑀1 Subunit
Examining the Neuronal Dopaminergic Pathway Underlying Sleep Behavior and Related Dopamine Sleep Disorders Mary Beth Putz University of San Diego
LSD) As a Model of Psychosis: Mechanism of Action and Pharmacology
Sparus Aurata)
Guidelines for ATC Classification and DDD Assignment 2021
Guidelines for ATC Classification and DDD Assignment 2011
Salvinorin A, a Kappa-Opioid Receptor Agonist Hallucinogen: Pharmacology and Potential Template for Novel Pharmacotherapeutic Agents in Neuropsychiatric Disorders
Reversal of Phencyclidine-Induced Dopaminergic Dysregulation by N-Methyl-D-Aspartate Receptor/Glycine-Site Agonists
Dopamine D2 Receptor-Mediated Inhibition of Dopaminergic Neurons
Determinants of Selective Receptor-G-Protein Coupling
Emulated Clinical Trials from Longitudinal Real-World
Pharmacological Activity of Salvinorin A, the Major Component of Salvia Divinorum
Moreira and Cordeiro-MS
Pharmacokinetics and Pharmacodynamics of Salvinorin a and Salvia Divinorum: Clinical and Forensic Aspects
COMPARISON of the WHO ATC CLASSIFICATION & Ephmra/PBIRG ANATOMICAL CLASSIFICATION
Implications in Human Disease and Signals Dopamine D2 Receptor
Tardive Dyskinesia and Dopamine Oxidation, Cumulative Effects
The Pharmacology of Lysergic Acid Diethylamide: a Review Torsten Passie1,Johnh.Halpern2,3, Dirk O
A Multi-Locus Approach to Treating Fibromyalgia by Boosting
Dopaminergic Treatment of Restless Legs Syndrome and Periodic Limb Movement Disorder
Comptuational Approaches for the Characterization of The
Dopamine D2 Receptor Priming Enhances Dopaminergic Response to Amphetamine in the Nucleus Accumbens: Role of the D1 and D2 Receptors
Repeated Phencyclidine Treatment Induces Negative
Incidence of Antidepressant Use Among Community Dwellers With